Utama › Purpura Trombositopenik Idiopatik › Illinois
Kajian klinikal Purpura Trombositopenik Idiopatik di Illinois
4 kajian untuk Purpura Trombositopenik Idiopatik sedang mencari peserta di lokasi di Illinois.
Teks kajian rasmi (Bahasa Inggeris)
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
- Hope And Healing Care, Hinsdale
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07421167A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- Bleeding and Clotting Disorders Institute, Peoria
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06721013A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
- The Bleeding and Clotting Disorders Institute, Peoria
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07700238A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- The University of Chicago Medicine, Chicago
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Mei 2026 · NCT06544499Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.